|
|
||||||||
From the Department of Medicine, Harvard Medical School, Farber Cancer Center, Boston, Massachusettes 02115 and Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Abstract
Immunization with increasing doses of SRBC, in excess of 108, results in a progressive decline in the anti-SRBC PFC response. This hyporesponsive state is antigen specific and is reflected in a decrease of both T helper and B antibody-forming activity. We asked whether the apparent defect of T helper activity reflected a) an absence of
SRBC helper T cell activity, or b) the presence of SRBC-specific suppressor T cells within the hyporesponsive population. Our results indicate that at least a portion of hyporesponsiveness noted after antigen exposure to large doses of antigen can be ascribed to specific suppressor T cell activation.
Fractionation of the suppressive T cell population using Ly antiserum showed that specific suppressive activity was mediated by a subclass of T cells (Ly2+), distinct from that committed to express helper function (Ly1).
Footnotes
1 This work was supported by United States Public Health Service Research Grants AI12184 and AI13600.
2 Scholar of the Leukemia Society of America.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |